Data Critical gets clearance for wireless telemedicine

Article

Data Critical gets clearance for wireless telemedicineWireless telemedicine developer Data Critical of Redmond, WA, has received clearance from the Food and Drug Administration for its RhythmStat XL system, which enables healthcare professionals

Data Critical gets clearance for wireless telemedicine

Wireless telemedicine developer Data Critical of Redmond, WA, has received clearance from the Food and Drug Administration for its RhythmStat XL system, which enables healthcare professionals to receive ECG waveforms on a palmtop computer. The technology should help caregivers respond more quickly to patients who are suffering from cardiac arrhythmias.

Patients using RhythmStat XL can record their ECGs with an event recorder, and send the information directly to physicians over a conventional or cellular phone line. The signal is then converted into a visual display of the patient's ECG on a Psion 3C palmtop computer carried by the physician. RhythmStat XL can store up to 50 minutes of patient ECGs.

Data Critical is also developing other wireless-based telemedicine technologies, including StatView, a pager-sized device designed for nurses that can also display cardiac information like ECG waveforms. Another product designed for physicians, MobileView, is based on a Nokia 9000 Communicator device, which combines cellular phone, data transmission, and personal organizer functions into a small, clamshell-style unit. Physicians using MobileView have access to information such as blood pressure, sinus rhythm, and pulse. StatView is pending FDA clearance.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.